-
Megacystis at 10-14 weeks of gestation: chromosomal defects and outcome according to bladder length.
Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:338-41. -
Sonographic markers of fetal aneuploidy: a review.
Cicero S, Sacchini C, Rembouskos G, Nicolaides KH.
Placenta 2003;24:S88-98. -
Absent nasal bone at 11-14 weeks of gestation and chromosomal defects.
Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:31-5. -
Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks.
Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;22:135-7. -
First-trimester maternal serum PAPP-A, SP1 and M-CSF levels in normal and trisomic twin pregnancies.
Bersinger NA, Noble P, Nicolaides KH.
Prenat Diagn 2003;23:157-62. -
Distribution of fetal erythroblasts enriched from maternal blood in multifetal pregnancies.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
Hum Reprod 2003;18:1933-6. -
Fetal erythroblasts in maternal blood in relation to gestational age.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
J Matern Fetal Neonatal Med 2003;14:392-7. -
Distribution of fetal erythroblasts in maternal blood after chorionic villous sampling.
Al-Mufti R, Hambley H, Farzaneh F, Nicolaides KH.
BJOG 2003;110:33-8. -
Comparison of color Doppler uterine artery indices in a population at high risk for adverse outcome at 24 weeks' gestation.
Albaiges G, Missfelder-Lobos H, Parra M, Lees C, Cooper D, Nicolaides KH.
Ultrasound Obstet Gynecol 2003;21:170-3. -
The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, Stark GB, Alitalo K, Tomarev SI, Niemeyer C, Rossler J.
FASEB J 2002;16:1271-3. -
A first trimester trisomy 13/trisomy 18 risk algorithm combining fetal nuchal translucency thickness, maternal serum free beta-hCG and PAPP-A.
Spencer K, Nicolaides KH.
Prenat Diagn 2002;22:877-9. -
Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.
Savvidou MD, Lees CC, Parra M, Hingorani AD, Nicolaides KH.
BJOG 2002;109:297-301. -
Second-trimester uterine artery Doppler screening in unselected populations: a review.
Papageorghiou AT, Yu CK, Cicero S, Bower S, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;12:78-88. -
Increased fetal nuchal translucency at 11-14 weeks.
Nicolaides KH, Heath V, Cicero S.
Prenat Diagn 2002;22:308-15. -
One-stop clinic for assessment of risk of chromosomal defects at 12 weeks of gestation.
Nicolaides KH, Bindra R, Heath V, Cicero S.
J Matern Fetal Neonatal Med 2002;12:9-18. -
Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening.
Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides KH.
Ultrasound Obstet Gynecol 2002;19:443-8. -
Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation.
Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH.
J Matern Fetal Neonatal Med 2002;11:400-2. -
Screening for chromosomal defects by fetal nuchal translucency at 11 to 14 weeks.
Bindra R, Heath V, Nicolaides KH.
Clin Obstet Gynecol 2002;45:661-70. -
First trimester maternal serum placenta growth factor (PlGF)concentrations in pregnancies with fetal trisomy 21 or trisomy 18.
Spencer K, Liao AW, Ong CY, Geerts L, Nicolaides KH.
Prenat Diagn 2001;21:718-22. -
Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy.
Savvidou MD, Vallance PJ, Nicolaides KH, Hingorani AD.
Hypertension 2001;38:1289-93.